Is Ischemic Preconditioning a Useful Therapeutic Strategy in Liver Transplantation? Results from the First Pilot Study in Mexico

Archives of Medical Research

Volumn 46, Issue 4, 2015, Pages 296-302

  Zapata Chavira, Homero A ^a   Cordero Pérez, Paula ^a   Casillas Ramírez, Araní ^b   Escobedo Villarreal, Miguel M ^a   Pérez Rodríguez, Edelmiro ^a   Torres González, Liliana ^a   Camara Lemarroy, Carlos ^a   Hernández Guedea, Marco A ^a   Caballero Mendoza, Eloy ^a   Muñoz Espinosa, Linda E ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^b Hospital Regional de Alta Especialidad Bicentenario 2010   (Mexico)

Author keywords

Ischemia reperfusion injury; Ischemic preconditioning; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HYPERTENSIVE FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LEUKOTRIENE B4; MYELOPEROXIDASE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ALCOHOL ABUSE; ARTICLE; AUTOIMMUNE DISEASE; BILIARY CIRRHOSIS; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL STUDY; COLD ISCHEMIA; DEMOGRAPHY; FALSE ANEURYSM; FATTY LIVER; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ARREST; HEPATITIS B; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; INTENSIVE CARE; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEXICO; NEUTROPHIL CHEMOTAXIS; OVERALL SURVIVAL; PILOT STUDY; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; TRAUMATIC BRAIN INJURY; ADVERSE EFFECTS; BLOOD; CADAVER; CONTROLLED STUDY; DONOR; END STAGE LIVER DISEASE; LIVER; MIDDLE AGED; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CADAVER; END STAGE LIVER DISEASE; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; MALE; MEXICO; MIDDLE AGED; PILOT PROJECTS; REPERFUSION INJURY; TISSUE DONORS; YOUNG ADULT;

EID: 84936946715     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.06.002     Document Type: Article

References (31)

1. Rougemont O., Lehmann K., Clavien P. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl 2009, 15:1172-1182.
2. Cameron A., Ghobrial M., Yersiz H., et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006, 243:748-755.
3. Fondevila C., Busuttil R.W., Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003, 74:86-93.
4. Serafin A., Rosello-Catafau J., Prats N., et al. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia-reperfusion. Hepatology 2004, 39:688-698.
5. Arranz J., Soriano A., Garcia I., et al. Effect of proinflammatory cytokines (IL-6, TNF-α, IL-1β) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc 2003, 35:1884-1887.
6. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J PhysiolGastrointest Liver Physiol 2003, 284:15-26.
7. Becker T., Jüttner B., Elsner H., et al. Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection. Transpl Int 2004, 17:442-448.
8. Selzner N., Rudiger H., Graf R., et al. Protective strategies against ischemic injury of the liver. Gastroenterology 2003, 125:917-936.
9. Mendes-Braz M., Elias-Miró M., Jiménez-Castro M.B., et al. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol 2012, 2012:298657.
10. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
11. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000, 232:155-162.
12. Li S.Q., Liang L.J., Huang J.F., et al. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol 2004, 10:2580-2584.
13. Choukèr A., Martignoni A., Schauer R., et al. Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils. Arch Surg 2005, 140:129-136.
14. Desai K.K., Dikdan G.S., Shareef A., et al. Ischemic preconditioning of the liver: a few perspectives from the bench to bedside translation. Liver Transpl 2008, 14(11):1569-1577.
15. Franchello A., Gilbo N., David E., et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusionInjury (IRI). Am J Transplant 2009, 9:1629-1639.
16. Esposti D., Sebagh M., Pham P., et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes. Cell Death Dis 2011, 2:1-8.
17. Andreani P., Hoti E., De la Serna S., et al. Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance. HPB 2010, 12:439-446.
18. Azoulay D., Del Gaudio M., Andreani P., et al. Effects of 10 min of ischemic preconditioning of the cadaveric liver on the grafts preservation and function: the ying and the yang. Ann Surg 2005, 242:133-139.
19. Amador A., Grande L., Marti J., et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007, 7:2180-2189.
20. Briceño J., Solórzano G., Pera C. A proposal for scoring marginal liver grafts. Transpl Int 2000, S1:249-252.
21. Chen H., Xie J., Shen B., et al. Initial poor graft dysfunction and primary graft non-function after orthotopic liver transplantation. Liver Biopsy in Modern Medicine 2011, 183-206. InTech China, Shanghai. 1st ed. Y. Mizuguchi (Ed.).
22. Parsons R.F., Guarrera J.V. Preservation solutions for static cold storage of abdominal allografts: which is best?. Curr Opin Organ Transplant 2014, 19:100-107.
23. Jassem W., Fuggle S., Cerundolo L., et al. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006, 81:169-174.
24. Cescon M., Grazi G., Grassi A., et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006, 12:628-635.
25. Koneru B., Shareef A., Dikdan G., et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007, 7:2788-2796.
26. Koneru B., Fisher A., He Y., et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005, 11:196-202.
27. Singhal A.K., Sheng X., Drakos S.G., et al. Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc 2009, 41:3539-3544.
28. Rech T.H., Moraes R.B., Crispim D., et al. Management of the brain-dead organ donor: a systematic review and meta-analysis. Transplantation 2013, 95:966-974.
29. Massip-Salcedo M., Roselló-Catafau J., Prieto J., et al. The response of the hepatocyte to ischemia. Liver Int 2007, 27:6-16.
30. Jiménez-Castro M.B., Meroño N., Mendes-Braz M., et al. The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning. J Hepatol 2015, 62:83-91.
31. Estado Actual de Receptores, Donación y Trasplantes en México 1ER Semestre 2014 Centro Nacional de Trasplantes. http://www.cenatra.salud.gob.mx/interior/trasplante_estadisticas.html.